2m 2m 2m 2m 2m 2m 2m
VTV THERAP-A (VTVT)
NASDAQ
$27.15-$0.62 (-2.23%)
Price as of Oct 22, 2026 4:54 PM EDT- $109.8MMarket Cap
- 33.57%1-Year Change
- BiotechnologyIndustry
VTV THERAP-A (VTVT)
$27.15-$0.62 (-2.23%)
VTVT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $27.77 | ||
Change | -$0.07 (-0.27%) | ||
Open | $28.06 | ||
High | $29.24 | ||
Low | $27.55 | ||
Previous Close | $27.84 | ||
Volume | 14,147 | ||
30-Day Average Volume | 29,238 | ||
1-Week Change | 0.91% | ||
1-Month Change | -11.28% | ||
1-Year Change | 33.57% | ||
3-Year Change | 61.45% | ||
5-Year Change | -51.79% | ||
Fundamentals | |||
Shares Outstanding | 4.0M | ||
Total Assets | $87.6M | ||
Market Cap | $109.8M | ||
Enterprise Value | $23.2M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$13.1M | ||
Free Cash Flow | -$11.4M | ||
EBIT | -$13.1M | ||
EBITDA | -$13.1M | ||
Net Working Capital | $80.6M | ||
EPS | -$1.05 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -26 | ||
PEG | 0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 40 | ||
Last Split Date | 11/21/2023 | ||
Earnings & Revenue